2018 American Transplant Congress » Concurrent Session: Kidney Immunosuppression: Co-Stimulation Based Regimens

Date: Sunday, June 3, 2018

Time: 4:30pm-6:00pm

Location: Room 6C

Session Type: Concurrent Session

Meeting: 2018 American Transplant Congress

4:30pm-4:42pm: Immunophenotype of Cells Infiltrating the Graft Explains the Benefits of Belatacept

J. Furuzawa-Carballeda,¹ N. Uribe-Uribe,² G. Mondragon-Ramirez,⁴ J. Arreola-Guerra,⁵ R. Reyes-Acevedo,⁵ M. Vilatoba,³ R. Chavez-Fernandez,¹ F. Lopez-Verdugo,¹ A. Lopez-Toledo,⁴ G. Mondragon-Salgado,⁴ J. Alberu.³

4:42pm-4:54pm: The BEST Trial: A Prospective Randomized Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression

E. Woodle,¹ D. Kaufman,² A. Shields,¹ J. Leone,³ A. Wiseman,⁴ A. Matas,⁵ P. West-Thielke,⁶ E. King,¹ R. Alloway.¹

4:54pm-5:06pm: Clinical Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in Highly Sensitized Kidney Transplant Recipients

S. Sethi, J. Choi, A. Vo, A. Peng, K. Lim, R. Najjar, S. Jordan, E. Huang.

5:06pm-5:18pm: Belatacept Maintenance Immunosuppression Use and Outcomes in the Real-World Clinical Setting Using OPTN/UNOS Kidney Transplant Registry

S. Sanoff,¹ K. Ravindra,¹ W. Irish.^1,2

5:18pm-5:30pm: Belatacept in Kidney Transplant Recipients with Preformed Donor Specific Anti-HLA Antibodies: Results of the BELACOR Trial

C. Leibler,¹ F. Canoui,² M. Matignon,¹ E. Rondeau,³ A. Zarour,² A. Durrbach,⁴ S. Malard,⁵ P. Grimbert.¹

5:30pm-5:42pm: Tissue Talks: Graft´s Histological Findings 10 Years after Belatacept or CNI

G. Mondragon-Ramirez,¹ N. Uribe-Uribe,² J. Arreola-Guerra,⁵ R. Reyes-Acevedo,⁵ M. Vilatoba,³ J. Furuzawa-Carballeda,⁴ A. Lopez-Toledo,¹ G. Mondragon-Salgado,¹ J. Alberu.³

5:42pm-5:54pm: Precision Medicine for Determining the Efficacy of a Novel Belatacept Regimen

J. Shoji, J. Leung, E. Tavares, Q. Tang, F. Vincenti.

« View all sessions from the 2018 American Transplant Congress